Foetal-Placental Neuroendocrine Development

Foetal Placental Neuroendocrine development involves mother, foetus, and placenta, and stress is a key element activating a series of physiological adaptive responses. Oxytocin (OT) is the neurohormone whose major target is uterine contractility and placenta represents a novel source that contributes to the mechanisms of parturition. Among the others, neurohormones, relaxin, parathyroid hormone-related protein, opioids, neurosteroids, and monoamines are expressed and secreted from placental tissues at parturition.

 

    Related Conference of Foetal-Placental Neuroendocrine Development

    March 17-18, 2021

    30th European Diabetes Congress

    Barcelona, Spain
    March 22-23, 2021

    Global summit on Diabetes and Endocrinology

    London, UK
    April 13-14, 2021

    World congress on Endocrinology and Metabolic syndrome

    Auckland, Newzealand
    May 10-11, 2021

    30th World Diabetes & Heart Congress

    Singapore, Singapore
    June 16-17, 2021

    World Summit on Diabetes

    Rome, Italy
    June 23-24, 2021

    Virtual event on Obesity and Hormones

    Rome, Italy
    September 02-03, 2021

    5th Annual Congress on Diabetes, Obesity and Its Complications

    Vienna, Australia
    October 14-15, 2021

    Global congress on Endocrinology and Gynecology

    Sydney, Australia
    October 18-19, 2021

    2nd Annual Summit on Diabetes and Endocrinology

    Paris, France
    November 16-17, 2021

    World congress and Expo on Diabetes

    Osaka, Japan
    November 16-17, 2021

    World congress and Expo on Diabetes

    Osaka, Japan
    December 07-08, 2021

    13th World Congress on Endocrinology and Metabolic Disorders

    Auckland, Newzealand

    Foetal-Placental Neuroendocrine Development Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in